Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001754067-24-000004
Filing Date
2024-01-09
Accepted
2024-01-09 16:07:01
Documents
3
Period of Report
2024-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1704834409.html 3  
1 FORM 3 wk-form3_1704834409.xml 3 1710
2 EX-24 kellytim-poa.htm EX-24 596
3 kellytim-poa001.jpg GRAPHIC 198397
  Complete submission text file 0001754067-24-000004.txt   277062
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Issuer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O HOMOLOGY MEDICINES, INC. ONE PATRIOTS PARK BEDFORD MA 01730
Business Address
Kelly Timothy P (Reporting) CIK: 0001754067 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40631 | Film No.: 24523317